Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this Clinical Trial is to verify the effectiveness of the use of the Intorus device in the motor intervention in patients with cerebral palsy and related syndromes. The main question it aims to answer is:
Does the use of the Intorus tool manage to improve the mobility of upper limbs (MMSS) in patients with infantile cerebral palsy to increase their performance in activities of daily living? A total of approximately 50 users will participate in the study. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the motor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the motor level with the INTORUS device.
Randomization will be carried out using the Oxford Minimization and Randomization software.
The intervention program will take place during the Occupational Therapy sessions and will be carried out by the center's occupational therapists. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the patient attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs.
Each session will consist of several exercises with their corresponding rest breaks.
EVALUATION
The evaluations will be carried out prior to the start of treatment, at 20 weeks of treatment and at 40 weeks of treatment once the intervention program has concluded.
The tools used to carry out the evaluation will be:
Questionnaire of sociodemographic variables
Goniometric
Gross Motor Function Classification
Assessment of a functional gesture
Satisfaction questionnaire for professionals The evaluations will be carried out by a professional external to the center to avoid bias.
Once the intervention period is over, a questionnaire will be passed to the professionals participating in the study to assess the usefulness of the device, the degree of satisfaction with it and the usefulness of the therapies applied.
TIMELINE The intervention consists of 40 treatment sessions lasting 45 minutes each with a frequency of 2 days a week in which the intervention program described above will be developed.
Previously, the participants will receive a "session 0" in which they will carry out a first contact with the device.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental group | Experimental | This group receives motor intervention sessions with the Intorus device |
|
| Control group | No Intervention | This group receives no motor intervention sessions with the Intorus device |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| INTORUS | Device | Motor intervention protocol with Intorus consisting of a series of exercises of progressive difficulty |
|
| Measure | Description | Time Frame |
|---|---|---|
| IMPROVEMENT OF UPPER LIMB MOBILITY AS MEASURED BY GONIOMETER | Measuring joint amplitude of upper limb joints with goniometer | Before starting treatment. After 20 weeks of treatment and at the end of treatment (40 weeks). |
| Measure | Description | Time Frame |
|---|---|---|
| Functional Gesture of Activities of Daily Living | Measurement of the performance of a functional gesture performed in the patient's activities of daily living. | Before starting treatment. After 20 weeks of treatment and at the end of treatment (40 weeks). |
| Measure | Description | Time Frame |
|---|---|---|
| Professional satisfaction questionnaire | Measurement of professionals' satisfaction with the use of the tool measured with a questionnaire designed by ourselves. | Through study completion, an average of 6 months |
| Participants satisfaction questionnaire |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Blanca González Sánchez, Doctor | Universidad de Extremadura | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Blanca González Sánchez | Cáceres | Caceres | 10001 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002547 | Cerebral Palsy |
| D000068079 | Motor Disorders |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D001925 | Brain Damage, Chronic |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Measurement of participants' satisfaction with the use of the tool measured with a questionnaire designed by us.
| Through study completion, an average of 6 months |
| D001523 | Mental Disorders |
| D001519 | Behavior |